HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 281 filers reported holding HAEMONETICS CORP in Q4 2018. The put-call ratio across all filers is 2.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,961,296 | +6.6% | 111,200 | +1.3% | 0.01% | +33.3% |
| Q2 2023 | $9,348,372 | +3.5% | 109,800 | +0.5% | 0.01% | 0.0% |
| Q1 2023 | $9,036,300 | -7.3% | 109,200 | -11.9% | 0.01% | -14.3% |
| Q4 2022 | $9,752,600 | +8.3% | 124,000 | +2.0% | 0.01% | +16.7% |
| Q3 2022 | $9,002,000 | +14.3% | 121,600 | +0.7% | 0.01% | +20.0% |
| Q2 2022 | $7,874,000 | +3.1% | 120,800 | 0.0% | 0.01% | +25.0% |
| Q1 2022 | $7,637,000 | +28.2% | 120,800 | +7.6% | 0.00% | 0.0% |
| Q4 2021 | $5,956,000 | -24.9% | 112,300 | 0.0% | 0.00% | -20.0% |
| Q3 2021 | $7,927,000 | +6.2% | 112,300 | +0.3% | 0.01% | 0.0% |
| Q2 2021 | $7,464,000 | -42.1% | 112,000 | -3.5% | 0.01% | -44.4% |
| Q1 2021 | $12,888,000 | -5.3% | 116,100 | +1.3% | 0.01% | -10.0% |
| Q4 2020 | $13,609,000 | +36.6% | 114,600 | +0.4% | 0.01% | +25.0% |
| Q3 2020 | $9,964,000 | -0.9% | 114,200 | +1.7% | 0.01% | -11.1% |
| Q2 2020 | $10,058,000 | +2.7% | 112,300 | +14.2% | 0.01% | -10.0% |
| Q1 2020 | $9,797,000 | -12.3% | 98,300 | +1.1% | 0.01% | -9.1% |
| Q4 2019 | $11,168,000 | -8.2% | 97,200 | +0.8% | 0.01% | -15.4% |
| Q3 2019 | $12,160,000 | +6.5% | 96,400 | +1.6% | 0.01% | +8.3% |
| Q2 2019 | $11,420,000 | +38.6% | 94,900 | +0.7% | 0.01% | +33.3% |
| Q1 2019 | $8,241,000 | -9.9% | 94,200 | +3.1% | 0.01% | -25.0% |
| Q4 2018 | $9,145,000 | -12.4% | 91,400 | +0.3% | 0.01% | 0.0% |
| Q3 2018 | $10,438,000 | +25.0% | 91,100 | -2.1% | 0.01% | +20.0% |
| Q2 2018 | $8,349,000 | +24.6% | 93,100 | +1.6% | 0.01% | +25.0% |
| Q1 2018 | $6,701,000 | +28.8% | 91,600 | +2.2% | 0.01% | +33.3% |
| Q4 2017 | $5,204,000 | +32.6% | 89,600 | +2.4% | 0.01% | +50.0% |
| Q3 2017 | $3,926,000 | +13.6% | 87,500 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $3,455,000 | -0.4% | 87,500 | +2.3% | 0.00% | 0.0% |
| Q1 2017 | $3,469,000 | +2.4% | 85,500 | +1.4% | 0.00% | -20.0% |
| Q4 2016 | $3,389,000 | +15.1% | 84,300 | +3.7% | 0.01% | 0.0% |
| Q3 2016 | $2,944,000 | +20.6% | 81,300 | -3.4% | 0.01% | +25.0% |
| Q2 2016 | $2,441,000 | -13.4% | 84,200 | +0.8% | 0.00% | -20.0% |
| Q1 2016 | $2,820,000 | +28.2% | 83,500 | +22.4% | 0.01% | 0.0% |
| Q4 2015 | $2,199,000 | -0.2% | 68,200 | 0.0% | 0.01% | -16.7% |
| Q3 2015 | $2,204,000 | -10.3% | 68,200 | +14.8% | 0.01% | 0.0% |
| Q2 2015 | $2,457,000 | -6.8% | 59,400 | +1.2% | 0.01% | -14.3% |
| Q1 2015 | $2,637,000 | +22.1% | 58,700 | +1.7% | 0.01% | -12.5% |
| Q4 2014 | $2,159,000 | +8.5% | 57,700 | +1.2% | 0.01% | 0.0% |
| Q3 2014 | $1,990,000 | -2.4% | 57,000 | -1.4% | 0.01% | 0.0% |
| Q2 2014 | $2,039,000 | +8.2% | 57,800 | 0.0% | 0.01% | +14.3% |
| Q1 2014 | $1,884,000 | -0.6% | 57,800 | +28.4% | 0.01% | 0.0% |
| Q4 2013 | $1,896,000 | +6.8% | 45,000 | +1.1% | 0.01% | 0.0% |
| Q3 2013 | $1,775,000 | -9.3% | 44,500 | -5.9% | 0.01% | -22.2% |
| Q2 2013 | $1,956,000 | – | 47,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BEACONLIGHT CAPITAL, LLC | 95,033 | $8,511,000 | 2.84% |
| Advantage Alpha Capital Partners LP | 100,170 | $8,971,000 | 2.10% |
| Nitorum Capital, L.P. | 395,635 | $35,433,000 | 1.82% |
| Summit Creek Advisors LLC | 127,600 | $11,428,000 | 1.68% |
| Bridge City Capital, LLC | 40,559 | $3,632,000 | 1.67% |
| AEGON ASSET MANAGEMENT UK PLC | 520,408 | $46,603,000 | 1.05% |
| Jackson Square Partners, LLC | 2,298,190 | $205,825,000 | 1.03% |
| Parkman Healthcare Partners LLC | 30,147 | $2,700,000 | 0.76% |
| TEALWOOD ASSET MANAGEMENT INC | 9,154 | $820,000 | 0.54% |
| AMERICAN CAPITAL MANAGEMENT INC | 159,145 | $14,253,000 | 0.52% |